ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 275 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,005,015 | +3110.2% | 275,788 | +5026.2% | 0.02% | +1700.0% |
| Q4 2022 | $218,213 | -97.1% | 5,380 | -97.6% | 0.00% | -95.7% |
| Q3 2022 | $7,459,000 | +20.2% | 225,683 | +28.1% | 0.02% | +15.0% |
| Q2 2022 | $6,204,000 | +568.5% | 176,194 | +773.1% | 0.02% | +566.7% |
| Q1 2022 | $928,000 | +36.5% | 20,181 | +96.8% | 0.00% | +50.0% |
| Q4 2021 | $680,000 | -91.4% | 10,257 | -91.9% | 0.00% | -93.9% |
| Q3 2021 | $7,895,000 | -26.7% | 126,470 | -2.7% | 0.03% | -35.3% |
| Q2 2021 | $10,767,000 | +306.3% | 130,000 | +276.3% | 0.05% | +240.0% |
| Q4 2020 | $2,650,000 | +105.1% | 34,543 | +15.1% | 0.02% | +66.7% |
| Q3 2020 | $1,292,000 | +92.5% | 30,000 | +183.7% | 0.01% | +125.0% |
| Q4 2019 | $671,000 | – | 10,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |